Packaging and Distribution

Herma’s new label removal unit reduces the time for discharging misprinted labels by more than half.

Shipping biopharmaceuticals in single-use containers requires a thorough understanding of the distribution cycle and potential transportation risks.

Increased use of single-use systems has led to a need to redefine safe, stable and integral systems for shipping biopharmaceuticals around the world. This article provides qualification data under international ASTM D4169 norms.

The company will showcase its drum-filling technology among other products and services at the upcoming ACHEMA 2018 event in Frankfurt, Germany.

INTERPHEX presents advances in pharmaceutical container filling, robotic handling, and serialization.

This workshop, to be held in Sheffield, United Kingdom, on June 7, 2018, will provide an introduction to the use of glass as primary pharmaceutical packaging.

The company will build a high-volume manufacturing facility for their glass packaging product in Durham County, NC.

New filling and inspection machines and new containers and closures for injectable drugs will be on display at INTERPHEX 2018.

Keystone Folding Box has added a new line of secondary packaging systems for injectable pharmaceutical products.

Helsinn will acquire the global rights to Valchlor/Ledaga (mechlorethamine/chlormethine), a topical skin-cancer drug, from Actelion Pharmaceuticals.

Revisions to chapters on glass containers and elastomeric closures were canceled following review of comments.

Machine vision and optical character recognition technologies enhance inspection of packages and labels.

Stability testing on APIs/finished drug product helps define optimal drug packaging for shelf-life storage.

The company is voluntarily recalling three lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial and one lot of Labetalol Hydrochloride Injection, USP, Novaplus because of the potential of cracked glass at the rim of the vials.

Automation systems, vehicles, and robots improve efficiency of transporting materials and finished goods in pharmaceutical warehouses.

The Multi-Chamber Blister System is a blister package that incorporates Amcor's SafeMix cold form laminate to transport vaccines and sensitive APIs without the need for cool storage.

The Awards honor innovations in drug delivery and packaging, for better patient safety and compliance.

The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.

Labels must have special features to prevent tampering of pharmaceutical packaging.

The Tamper Evident Labeller from LSS Labelling Systems Scandinavia is compliant with the European Falsified Medicines Directive.

Closures that protect solid-dosage drugs and the capping equipment that applies them have new product-protecting features.

The development of new packaging solutions that are fit for drugs of the future requires close collaboration between the pharmaceutical manufacturer and its packaging suppliers and machine vendors.

Measurements by a drone-based online pressure monitoring system help identify weak points in the filling line, enabling the process to be optimized.

Glass and plastic are well established primary packaging materials for the pharmaceutical industry but they both have their advantages and disadvantages.

Implementation of the Packaging Serialization Standard cuts serialization costs, shortens deployment time, and expedites compliance with anticounterfeiting regulations.

Aero Pump’s preservative-free Multidose Eye Dropper System with SideActuationDevice received the CPhI Pharma Award for Excellence in Pharma: Packaging.

The facilities in Brescia, Italy and Karlskoga and Uppsala, Sweden, are the latest of Recipharm’s sites to be equipped to supply serialized products to the United States.

Bormioli Rocco Pharma offers new packaging solutions for powdered oral drugs, parenteral drugs, pediatric syrups, and protein-based drugs.

The voluntary recall is due to blister packages containing the incorrect product.

The agency published guidance regarding OTC aspirin products that have cardiovascular-related images in their labels.